Presentations we supply
- Injection 50 mg/2 ml
- Injection 500 mg/5 ml
- Injection 1000 mg/10 ml
Tell us whether you need the originator brand or a generic, the strength, pack and quantity, and the destination country.
Send Enquiry for MethotrexateReference information
Summarised from the product information for Methotrexate 100 mg/ml solution for injection (UK product information). Always follow the product information approved in your own country.
- Active substance
- Methotrexate
- Pharmacotherapeutic group
- Antineoplastic and immunosuppressive drugs, cytostatics, antimetabolites (ATC code L01BA01)
- Authorised uses
- Acute lymphoblastic leukaemias, in combination with other cytotoxic medicines
- Non-Hodgkin's lymphomas of intermediate and high malignancy, in adults and children
- Metastatic or recurrent head and neck cancer, as palliative single-agent treatment
- Breast cancer, adjuvant and palliative, in combination
- Choriocarcinoma and similar trophoblastic diseases
- Osteosarcoma, adjuvant and neoadjuvant, in combination
- Bladder cancer, in combination with other cytotoxic medicines
- Storage (unopened)
- Do not store above 25 °C. Keep the vial in the outer carton in order to protect from light.
- Shelf life (unopened)
- 2 years
- Container and pack
- 10 ml or 50 ml in a Type I clear glass vial with chlorobutyl rubber stopper and flip-off seal; pack of 1 vial
Supply from Bio Bridge Pharma
- The registration route and import licence are confirmed for your destination before we make an offer.
- Documents agreed before you order, such as the batch certificate of analysis and a CoPP where your regulator needs one.
- Named patient supply where the destination country's rules allow it.
Sources
- Product information for Methotrexate 100 mg/ml solution for injection: www.medicines.org.uk